Latest filing published 25 Aug 2017 for Harvard Apparatus Regenerative Technology, Inc., €31k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -45.5%Entry US$6.06 · Close at T+365 US$3.30
- -47.8%Entry US$6.32 · Close at T+365 US$3.30
- -62.5%Entry US$48.00 · Close at T+365 US$18.00
- +11.0%Entry US$18.92 · Close at T+365 US$21.00
- -13.6%Entry US$25.00 · Close at T+365 US$21.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Saverio LaFrancesca: trading record in brief
Saverio LaFrancesca is a declared insider of Harvard Apparatus Regenerative Technology, Inc., with filings sourced from SEC (Form 4). We count 10 filings; the first trade dates from 30 June 2015 and the latest from 24 August 2017.
Market trades split into 8 purchases (€120k) and 1 sale (€4,247). Purchases outweigh sales by €116k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2017, the count stands at 2 purchases and no sales.
Half of the purchases are above €5,355 and half below. Ninety days after publication, 6 purchases show a median change of +23.4%, with the price up in 50% of them. They describe history only and say nothing certain about the share price ahead.
Most recently, on 25 August 2017, the filings show an open-market purchase worth €31k in Harvard Apparatus Regenerative Technology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Saverio LaFrancesca
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100,000 shares@ US$0.3743.6% of flowCommon StockSEC:0001144204-17-045073:0Canonical exit: 22 Nov 2017 (T+90)
- 150,000 shares@ US$0.3256.4% of flowCommon StockSEC:0001144204-17-044867:0Canonical exit: 21 Nov 2017 (T+90)
- 2,393 shares@ US$2.01Common StockSEC:0001144204-15-071783:1Canonical exit: 16 Mar 2016 (T+90)
- 2,393 shares@ US$1.93Common StockSEC:0001144204-15-071783:0
- 10,000 shares@ US$3.01Common StockSEC:0001144204-15-068880:0Canonical exit: 29 Feb 2016 (T+90)
- 5,000 shares@ US$1.29Common StockSEC:0001144204-15-055793:0Canonical exit: 17 Dec 2015 (T+90)
- 4,500 shares@ US$1.28Common StockSEC:0001144204-15-055793:1Canonical exit: 17 Dec 2015 (T+90)
- 10,284 shares@ US$1.22Common StockSEC:0001144204-15-055663:0
- 2,500 shares@ US$0.96Common StockSEC:0001144204-15-053289:0Canonical exit: 26 Nov 2015 (T+90)
9 of 9 declarations